Tianyin Pharmaceutical Co., Inc. (fka TPIY)

[TheHungryHippo]

Gingko mihuan is a TCM launched as a proprietary prescription oral liquid by Tianyin Pharmaceuticals in 2012. The product contains flavonoid and terpenoid gingko extracts. Flavonoids have been shown to possess potent antioxidant activity and are useful in reducing capillary fragility. Terpenoids are reported to inhibit platelet activating factor and reduce blood viscosity associated with certain cardiovascular disorders. Gingko Mihuan Oral Liquid was approved by the China Food and Drug Administration (CFDA) in 2012 and is commonly prescribed for the treatment of stroke. Tianyin Pharmaceuticals also plans to develop capsule and tablet formulations of Gingko mihuan.